Nanofiltration as a robust method contributing to viral safety of plasma‐derived therapeutics: 20 yearsʼ experience of the plasma protein manufacturers

The Role of Nanofiltration in the Pathogen Safety of Biologicals: An Update

(2019) Masaharu Inouye et al.   Current Nanoscience

Evaluation of the virus clearance capacity and robustness of the manufacturing process for the recombinant factor VIII protein, turoctocog alfa

(2017) Tracey W. Ellgaard et al.   PROTEIN EXPRESSION AND PURIFICATION

Pathogen safety of a pasteurized four-factor human prothrombin complex concentrate preparation using serial 20N virus filtration

(2017) Thomas Nowak et al.   TRANSFUSION

Effective inactivation of a wide range of viruses by pasteurization

(2017) Albrecht Gröner et al.   TRANSFUSION

Inactivation and removal of Zika virus during manufacture of plasma-derived medicinal products

(2016) Johannes Blümel et al.   TRANSFUSION

Single-use technology for solvent/detergent virus inactivation of industrial plasma products

(2016) Yao-Ting Hsieh et al.   TRANSFUSION

Characterization of Thrombate III®, a pasteurized and nanofiltered therapeutic human antithrombin concentrate

(2014) Kang Cai et al.   BIOLOGICALS

Pathogen safety of Beriate®

(2014) Albrecht Gröner   THROMBOSIS RESEARCH

Virus safety of plasma products using 20 nm instead of 15 nm filtration as virus removing step

(2012) A.H.L. Koenderman et al.   BIOLOGICALS

Pathogen safety of human C1 esterase inhibitor concentrate

(2012) Albrecht Gröner et al.   TRANSFUSION

Viral safety characteristics of Flebogamma® DIF, a new pasteurized, solvent-detergent treated and Planova 20 nm nanofiltered intravenous immunoglobulin

(2010) Santiago Caballero et al.   BIOLOGICALS

Evaluation of the Virus-elimination Efficacy of Nanofiltration (Viresolve NFP) for the Parvovirus B19 and Hepatitis A Virus

(2010) Deok Ja Oh et al.   Korean Journal of Laboratory Medicine

Robustness of solvent/detergent treatment of plasma derivatives: a data collection from Plasma Protein Therapeutics Association member companies

(2009) Herbert O. Dichtelmüller et al.   TRANSFUSION

Effectiveness of nanofiltration in removing small non-enveloped viruses from three different plasma-derived products

(2009) M. C. Menconi et al.   TRANSFUSION MEDICINE

Investigations of prion and virus safety of a new liquid IVIG product

(2008) M. Stucki et al.   BIOLOGICALS

A new liquid intravenous immunoglobulin with three dedicated virus reduction steps: virus and prion reduction capacity

(2008) G. Poelsler et al.   VOX SANGUINIS